The present study also demonstrated that PI3K/AKT signaling pathways are activated in esophageal cancer cells TE1 and ECA109, and that AKT is mainly expressed in the nucleus, consistent with previous reports [36,37]. The gene discussed is AKT1; the disease is esophageal cancer.